Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Earlier in 2025, the U.S. Food and Drug Administration (FDA) approved Ozempic® (semaglutide ... to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD).

Ozempic (semaglutide) is a brand-name prescription drug used to manage type 2 diabetes and lower the risk of kidney and heart complications in people with both diabetes and chronic kidney disease.

Several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg have been found in the United States. The FDA ...

Ozempic is not FDA approved for any uses ... and death from cardiovascular disease in adults with type 2 diabetes and chronic kidney disease • to help with long-term weight management in certain ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...

University of Pittsburgh Medical School researchers walk us through multiple approaches they’ve tried in the past, are currently using or plan to use in the future, as well as the significant ...